Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2

Dried blood spot (DBS) samples were collected during spring of 2020 from random and undiagnosed individuals in Stockholm, Sweden. Receiving DBS from 878 participants, we applied multiplexed serology assays to determine IgG and IgM levels against several versions of SARS-CoV-2 proteins (S, RBD, N).The data reports anonymised an normalised "relative antibody titers" obtained in the eluates of the DBS samples. The data can be made available for validation purposes and upon reasonable request. A reasonable request should contain:1) Name of PI and host organisation2) Contact details3) Scientific purpose of data access request4) Commitment to inform when the data has been used in a publication5) Commitment not to host or share the data outside the requesting organisation6) Statement of non-commercial use of data

于2020年春季，我们从瑞典斯德哥尔摩的随机且未确诊的个人中收集了干血斑（DBS）样本。收集到878名参与者的DBS样本后，我们应用了多重血清学检测方法，以确定针对多种版本的SARS-CoV-2蛋白（S、RBD、N）的IgG和IgM抗体水平。数据报告了从DBS样本的洗脱液中获得的匿名化且标准化后的“相对抗体滴度”。这些数据可用于验证目的，并在合理请求的情况下提供。合理的请求应包含以下内容：1）项目负责人姓名及其所属机构2）联系方式3）数据访问请求的科学目的4）承诺在出版物中使用数据时进行通知5）承诺不在请求机构之外托管或共享数据6）声明数据非商业用途